These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9927228)

  • 1. Re: "Hormone replacement therapy and risk of hospitalization for venous thromboembolism: a population-based study in southern Europe".
    Oger E; Scarabin PY
    Am J Epidemiol; 1999 Feb; 149(3):292-3. PubMed ID: 9927228
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormone replacement therapy and the risk of hospitalization for venous thromboembolism: a population-based study in southern Europe.
    Varas-Lorenzo C; García-Rodríguez LA; Cattaruzzi C; Troncon MG; Agostinis L; Perez-Gutthann S
    Am J Epidemiol; 1998 Feb; 147(4):387-90. PubMed ID: 9508106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic influence of hormone-replacement therapy on venous thromboembolism.
    Sumino H; Ichikawa S; Kumakura H; Takayama Y; Kurabayashi M
    Lancet; 2003 Oct; 362(9391):1242. PubMed ID: 14568759
    [No Abstract]   [Full Text] [Related]  

  • 4. Transdermal hormone therapy and the risk of stroke and venous thrombosis.
    Speroff L
    Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormone therapy and risk of venous thromboembolism: new insights from the ESTHER study].
    Canonico M; Scarabin PY
    Med Sci (Paris); 2008 Mar; 24(3):228-31. PubMed ID: 18334161
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women.
    Olié V; Canonico M; Scarabin PY
    Curr Opin Hematol; 2010 Sep; 17(5):457-63. PubMed ID: 20601871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen and progestogen effect on venous thromboembolism in menopausal women.
    Archer DF; Oger E
    Climacteric; 2012 Jun; 15(3):235-40. PubMed ID: 22612609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The risk of venous thromboembolism in women during hormone replacement therapy].
    Zeltzer D; Shapira I; Berliner S
    Harefuah; 1999 Aug; 137(3-4):124-6. PubMed ID: 10959301
    [No Abstract]   [Full Text] [Related]  

  • 9. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.
    Canonico M; Oger E; Plu-Bureau G; Conard J; Meyer G; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
    Circulation; 2007 Feb; 115(7):840-5. PubMed ID: 17309934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are some types of hormone therapy safer than others? Lessons from the Estrogen and Thromboembolism Risk study.
    Rexrode KM; Manson JE
    Circulation; 2007 Feb; 115(7):820-2. PubMed ID: 17309929
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombophilic profile of climacteric and menopausal women with venous thromboembolism.
    Margarido PF; D'Amico E; Bagnoli VR; Fonseca AM; Halbe HW; Pinotti JA
    Climacteric; 2002 Mar; 5(1):87-9. PubMed ID: 11974563
    [No Abstract]   [Full Text] [Related]  

  • 12. [The SBU revises its view on estrogen replacement therapy in climacteric. Evidently increased risk of thrombosis and breast cancer].
    Hovelius B
    Lakartidningen; 2002 Jul; 99(28-29):3014-5. PubMed ID: 12170508
    [No Abstract]   [Full Text] [Related]  

  • 13. Hormone therapy and risk for venous thromboembolism: comments and correction.
    Goldstein MR
    Ann Intern Med; 2001 Jan; 134(1):81. PubMed ID: 11187427
    [No Abstract]   [Full Text] [Related]  

  • 14. [The storm around hormonal replacement therapy].
    Heikinheimo O; Kaaja R
    Duodecim; 2002; 118(18):1833-5. PubMed ID: 12422665
    [No Abstract]   [Full Text] [Related]  

  • 15. Hormone replacement therapy and venous thromboembolism.
    Greer IA; Walker ID
    Climacteric; 1999 Sep; 2(3):224-31. PubMed ID: 11910601
    [No Abstract]   [Full Text] [Related]  

  • 16. Hormone therapy and risk for venous thromboembolism: comments and correction.
    Waitkevicz HJ; Axelrod D
    Ann Intern Med; 2001 Jan; 134(1):80-1. PubMed ID: 11187425
    [No Abstract]   [Full Text] [Related]  

  • 17. HRT and venous thromboembolism: more evidence of a link.
    Chen BH
    CMAJ; 2001 Jan; 164(1):87. PubMed ID: 11202677
    [No Abstract]   [Full Text] [Related]  

  • 18. Hormone therapy and risk for venous thromboembolism: comments and corrections.
    Peverill R
    Ann Intern Med; 2001 Jan; 134(1):80; author reply 81. PubMed ID: 11187426
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of NFE2L2 genetic polymorphism on the association between oral estrogen therapy and the risk of venous thromboembolism in postmenopausal women.
    Bouligand J; Cabaret O; Canonico M; Verstuyft C; Dubert L; Becquemont L; Guiochon-Mantel A; Scarabin PY;
    Clin Pharmacol Ther; 2011 Jan; 89(1):60-4. PubMed ID: 21107315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer and hormone replacement therapy.
    Barton M; Meyer MR; Bolton JL; Prossnitz ER
    Lancet; 2010 Jan; 375(9709):117-8; author reply 118-9. PubMed ID: 20109881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.